Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Dec;63(6):821-6.
doi: 10.1590/s1807-59322008000600019.

A comparison of vitamin A and leucovorin for the prevention of methotrexate-induced micronuclei production in rat bone marrow

Sampath Madhyastha  1 , Latha V Prabhu, V Saralaya, Rajalakshmi Rai
Affiliations
Comparative Study

A comparison of vitamin A and leucovorin for the prevention of methotrexate-induced micronuclei production in rat bone marrow

Sampath Madhyastha et al. Clinics (Sao Paulo). 2008 Dec.

Abstract

Introduction: Methotrexate, a folate antagonist, is a mainstay treatment for childhood acute lymphoblastic leukemia. It is also widely used in a low dose formulation to treat patients with rheumatoid arthritis. In rats, methotrexate is known to induce micronuclei formation, leading to genetic damage, while vitamin A is known to protect against such methotrexate-induced genetic damage. Leucovorin (folinic acid) is generally administered with methotrexate to decrease methotrexate-induced toxicity.

Objectives: We aimed to determine whether vitamin A and leucovorin differed in their capacity to prevent formation of methotrexate-induced micronuclei in rat bone marrow erythrocytes. The present study also aimed to evaluate the effect of combined treatment with vitamin A and leucovorin on the formation of methotrexate-induced micronuclei.

Methods: Male and female Wistar rats (n=8) were injected with 20 mg/kg methotrexate (single i.p. dose). The control group received an equal volume of distilled water. The third and fourth groups of rats received vitamin A (5000 IU daily dose for 4 successive days) and leucovorin (0.5 mg/kg i.p. dose for 4 successive days), respectively. The fifth and sixth groups of rats received a combination of vitamin A and a single dose of methotrexate and a combination of leucovorin and methotrexate, respectively. The last group of rats received a combination of leucovorin, vitamin A and single dose of methotrexate. Samples were collected at 24 hours after the last dose of the treatment into 5% bovine albumin. Smears were obtained and stained with May-Grunwald and Giemsa. One thousand polychromatic erythrocytes were counted per animal for the presence of micronuclei and the percentage of polychromatic erythrocyte was determined.

Results: Comparison of methotrexate-treated rats with the control group showed a significant increase in the percentage of cells with micronuclei and a significant decrease polychromatic erythrocyte percentage. Combined methotrexate and vitamin A therapy and combined methotrexate and leucovorin therapy led to significant decreases in the micronuclei percentage and an increase in polychromatic erythrocyte percentage when compared to rats treated with methotrexate alone. Leucovorin was found to be more effective than vitamin A against the formation of methotrexate-induced micronuclei.

Conclusions: Both vitamin A and leucovorin provided significant protection against genetic damage induced by methotrexate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The percentage of micronuclei-induction in various gropus of rats. Error bar indicates ± SE (n=8), Anova significance, F=53.145
Figure 2
Figure 2
The percentage of polychromatic erythrocyte in various gropus of rats. Error bar indicates ± SE (n=8), Anova significance, F=8.001
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kasahar Y, Nakai Y, Miura D, Yagi K, Hirabayashi K, Makita T. Mechanism of induction of micronuclei and chromosome aberration of micronuclei and chromosome aberrations in mouse bone marrow by multiple treatments of methotrexate. Mutat Res. 1992;280:117–28. - PubMed
    1. Clark CM, Kirby B, Morris AD, Davison S, Zaki I, Emerson R, et al. Combination treatment with methotrexate and cyclosporine for severe Recalcitrant psoriasis. Br J Dermatol. 1999;141:279–82. - PubMed
    1. Hoffmeister RT. Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med. 1983;75:69–73. - PubMed
    1. Tulandi T, Bret PM, Atri M, Senteman M. Treatment of ectopic pregnancy by transvaginal intratubal methotrexate administration. Obstet Gynecol. 1991;77:627–30. - PubMed
    1. Brown DL. Serial endovaginal sonography of ectopic pregnancies treated with methotrexate. Obset Gynecol. 1991;77:406–9. - PubMed

Publication types